As use of the popular anti-diabetic and weight-loss drug Ozempic skyrockets, so have concerns about the medication's side ...

President Donald Trump says pharma tariffs could go as high as 250%. UBS downgrades Novo Nordisk stock to neutral and lowers ...

How to come off Mounjaro without gaining weight — the expert's guide - Coming off GLP-1 drugs doesn’t have to mean inevitable ...

Novo Nordisk (NYSE: NVO) stock is testing the patience of buy-and-hold investors. Over the last five years, NVO stock is up more than 200%. However, in the last year, it’s down over 61% and more than ...